FRI-401-Direct-acting antiviral agents are not associated with an increased risk of hepatocellular carcinoma recurrence in liver transplant recipients with hepatitis C

Hepatitis C ◽

Antiviral Agents ◽

Transplant Recipients ◽

Direct Acting Antiviral ◽

Increased Risk ◽

Hepatocellular Carcinoma Recurrence ◽

Direct Acting ◽

962 – Direct-Acting Antiviral Agents are Not Associated with an Increased Risk of Hepatocellular Carcinoma Recurrence in Liver Transplantation Recipients with Hepatitis C

Gastroenterology ◽

10.1016/s0016-5085(19)40041-3 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-1222

Author(s):

Chung Sang Tse ◽

Ju Dong Yang ◽

Omar Y. Mousa ◽

Surakit Pungpapong ◽

Andrew Keaveny ◽

...

Keyword(s):

Liver Transplantation ◽

Hepatitis C ◽

Antiviral Agents ◽

Direct Acting Antiviral ◽

Increased Risk ◽

Hepatocellular Carcinoma Recurrence ◽

Direct Acting ◽

Are Hepatitis C Positive Female Liver Transplant Recipients Still at Increased Risk for Graft Failure? Re-Examining the Disparity in the Modern Era of Direct Acting Antiviral Agents

Transplantation Journal ◽

10.1097/tp.0000000000003683 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Dor Yoeli ◽

Rashikh A. Choudhury ◽

Hunter B. Moore ◽

Angela Sauaia ◽

Mary Ann Simpson ◽

...

Keyword(s):

Hepatitis C ◽

Graft Failure ◽

Antiviral Agents ◽

Transplant Recipients ◽

Direct Acting Antiviral ◽

Increased Risk ◽

Direct Acting ◽

Modern Era ◽

Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients

Transplantation Proceedings ◽

10.1016/j.transproceed.2017.09.057 ◽

2018 ◽

Vol 50 (2) ◽

pp. 631-633 ◽

Cited By ~ 2

Author(s):

F. Nogueras López ◽

A. López Garrido ◽

E.J. Ortega Suazo ◽

F. Vadillo Calles ◽

F. Valverde López ◽

...

Keyword(s):

Hepatitis C ◽

Liver Transplant ◽

Antiviral Agents ◽

Transplant Recipients ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Effect of Successful Treatment of Hepatitis C Virus Infection Recurrence With Direct-Acting Antiviral Agents on Physical Performance in Liver Transplant Recipients

Transplantation Proceedings ◽

10.1016/j.transproceed.2018.02.109 ◽

2018 ◽

Vol 50 (7) ◽

pp. 2027-2030

Author(s):

M. Wojtowicz ◽

P. Wilkowski ◽

E. Hryniewiecka ◽

T. Cieciura ◽

L. Paczek ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Agents ◽

Transplant Recipients ◽

Hepatitis C Virus Infection ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Direct Acting Antiviral Agents ◽

Infection Recurrence

Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis

Transplant Infectious Disease ◽

10.1111/tid.13047 ◽

2019 ◽

Vol 21 (2) ◽

pp. e13047 ◽

Cited By ~ 3

Author(s):

Jiaye Liu ◽

Buyun Ma ◽

Wanlu Cao ◽

Meng Li ◽

Wichor M. Bramer ◽

...

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Antiviral Agents ◽

Transplant Recipients ◽

Hepatitis C Virus Infection ◽

Genotype 1 ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus (HCV) Liver Transplant Recipients Treated with Pretransplant Direct-Acting Antiviral (DAA) Therapy

Gastrointestinal Tumors ◽

10.1159/000510341 ◽

2020 ◽

Vol 7 (4) ◽

pp. 134-143

Author(s):

Nicholas Lim ◽

Dupinder Singh ◽

Scott Jackson ◽

John R. Lake

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Liver Transplant ◽

Transplant Recipients ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Liver Transplant Recipients

Eradication of Hepatitis C in Renal Transplant Recipients With Sofosbuvir Based Direct Acting Antiviral Agents in Resources Sparse Country

The American Journal of Gastroenterology ◽

10.14309/00000434-201810001-00872 ◽

2018 ◽

Vol 113 (Supplement) ◽

pp. S484-S485

Author(s):

Farina Hanif ◽

Rajesh Mandhwani ◽

Ghulamullah Lail ◽

Syed Mudassir Laeeq ◽

Nasir Luck ◽

...

Keyword(s):

Hepatitis C ◽

Renal Transplant ◽

Antiviral Agents ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Role of Serum Nitric Oxide in Prediction of Hepatocellular Carcinoma in Hepatitis C Patients Treated with Direct - Acting Antiviral Agents

10.47829/jjgh.2020.5404 ◽

2020 ◽

Vol 05 (04) ◽

Author(s):

Basha OM ◽

Elsadek HM ◽

Shokry MM ◽

Elsaid HH ◽

Farag AA

Keyword(s):

Nitric Oxide ◽

Hepatitis C ◽

Antiviral Agents ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected Liver

Liver Cancer ◽

10.1159/000504889 ◽

2020 ◽

Vol 9 (3) ◽

pp. 261-274

Author(s):

Yoshiaki Shimizu ◽

Kuniaki Arai ◽

Taro Yamashita ◽

Tatsuya Yamashita ◽

Tetsuro Shimakami ◽

...

Keyword(s):

Hepatitis C ◽

Antiviral Agents ◽

Arterial Phase ◽

Hepatobiliary Phase ◽

Direct Acting Antiviral ◽

Infected Liver ◽

Direct Acting ◽

Direct Acting Antiviral Agents ◽

Enhanced Imaging

Prothrombin induced by vitamin K absence or antagonist‐II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C‐related cirrhosis treated with direct‐acting antiviral agents

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.16685 ◽

2021 ◽

Author(s):

Elisabetta Degasperi ◽

Riccardo Perbellini ◽

Roberta D’Ambrosio ◽

Sara Colonia Uceda Renteria ◽

Ferruccio Ceriotti ◽

...

Keyword(s):

Hepatitis C ◽

Vitamin K ◽

Antiviral Agents ◽

Direct Acting Antiviral ◽

Caucasian Patients ◽

Direct Acting ◽